Genalyte, San Diego, has made its SARS-CoV-2 Multi-Antigen Serology Panel available in Houston. Genalyte’s antibody testing site will be located at Houston’s Toyota Center (1510 Polk St.), with appointments available Monday through Friday from 8 am to 5 pm.

Cary Gunn, Genalyte.

Cary Gunn, Genalyte.

“With covid-19 cases continuing to rise in Houston, we feel it’s imperative to help meet the demand and crucial need for high-quality, extensive antibody testing in the community,” says Genalyte CEO Cary Gunn. “Determining a person or a population’s level of exposure is not only essential to facilitate research to continue to develop a better understanding of the virus, but also to arm Houstonians with the understanding of current or past exposure to covid-19.”

Genalyte’s SARS-CoV-2 Multi-Antigen Serology Panel is designed to test for SARS-CoV-2-specific antibodies. The serology test is able to detect the type of antibodies present in a person’s blood. Based on the type of antibodies present, the test may indicate the presence of an active or past infection.

Genalyte maintains a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory, which ensures test results meet and exceed industry standards for clinical laboratory testing. The Genalyte SARS-CoV-2 serology panel goes through rigorous validation efforts to ensure clinical effectiveness and is processed on the company’s FDA-cleared Maverick Diagnostic System. The Genalyte serology test also has a very low false-positive rate—with accuracy exceeding 99%.

Genalyte’s antibody testing service is meant for people who are no longer experiencing any symptoms and have been symptom-free for at least 14 days. Once a blood sample is drawn, it will be sent to the lab for processing, and results will be available to participants within 24 to 48 hours.

For more information, visit Genalyte.